Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WNT3A | P56704 | 9/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.51 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.51 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.47 |
| ▸ | HPGDS | O60760 | 1/20 | 0.46 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.43 |
| ▸ | PORCN | Q9H237 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27789206 | 0.87 | ROCK2 (0.62) | WNT3AALDH1A1PTPN1PTPN2ROCK2 | |
| SCHEMBL20029254 | 0.82 | ALDH1A1 (0.60) | ALDH1A1PTPN1ROCK2MGLL | |
| SCHEMBL20143373 | 0.79 | ALDH1A1 (0.62) | ALDH1A1MGLL | |
| SCHEMBL4870704 | 0.76 | PTPN1 (0.67) | WNT3APTPN1PTPN2 | |
| SCHEMBL11057368 | 0.75 | ALDH1A1 (0.59) | ALDH1A1PTPN1 | |
| SCHEMBL9363349 | 0.75 | POLB (0.73) | ALDH1A1ROCK2 | |
| SCHEMBL24367126 | 0.74 | ALDH1A1 (0.55) | ALDH1A1 | |
| SCHEMBL70304 | 0.74 | WNT3A (0.61) | WNT3APTPN1PTPN2PORCN | |
| SCHEMBL30338729 | 0.73 | PTPN1 (0.63) | WNT3AALDH1A1PTPN1PTPN2 | |
| SCHEMBL27851554 | 0.73 | PTPN1 (0.63) | WNT3APTPN1PTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023280294-A1 | TARGET AND SMALL MOLECULE COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES OR CENTRAL NERVOUS SYSTEM INJURY | 北京干细胞与再生医学研究院 | 2023-01-12 | — | — | WO | disclosed |